1989
DOI: 10.1016/0277-5379(89)90256-3
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Primary non-Hodgkin's lymphoma of the stomach: Changing aspects and therapeutic choices

Search citation statements

Order By: Relevance

Paper Sections

Select...
52
4
2
1

Citation Types

3
15
0
0

Year Published

Range
1990
1990
2023
2023

Publication Types

Select...
48
9

Relationship

0
57

Authors

Journals

citations

Cited by 57 publications

(18 citation statements)
references

References 17 publications

3
15
0
0
Order By: Relevance
How this paper cites the one you are viewing
“…Our results showed an 88% 5-year disease-free survival, which com pares favorably with the results reported for other patients with stage IE disease (most with intermediate histology) treated with various regimens during a similar time peri od [11,12,23,24], Optimal treatment for patients with intermediate histology is unresolved. In contrast to the report of Valicenti et al [24], in which most of the patients had local failure, our results showed that these patients had distant failure, suggesting that there may be a role for systemic treatment.…”
Section: Intermediate-histology Lymphoma
supporting
confidence: 79%
“…The results reported by Maor et al [11] and Burgers et al [ 19] are comparable to the results of series in which patients underwent gastrectomy with or without adjuvant treatment [2.4,9,10,12,15,20-23] and suggest that initial management with radiation with or without chemotherapy may produce comparable diseasefree survival and overall survival as compared with regi mens that include surgical treatment. Both Taal et al [12] and Valicenti et al [24] reached similar conclusions. In addition, Rao et al [25] found an equivalent long-term cure with biopsy plus radiation versus resection plus radiation in patients with stage IE disease.…”
Section: Initial Surgical Treatment
supporting
confidence: 71%
See 1 more Smart Citation